PRAX Q3 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$468,000

Gross Profit

-$17M-3588.0% margin

Operating Income

-$26M-5452.1% margin

Net Income

-$25M-5263.2% margin

EPS (Diluted)

$-2.72

QoQ Revenue Growth

-40.1%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$107M

Total Liabilities

$20M

Stockholders' Equity

$87M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$468,000	$0	—
Gross Profit	-$17M	-$30M	+44.8%
Operating Income	-$26M	-$44M	+42.4%
Net Income	-$25M	-$44M	+43.9%

Revenue Segments

License

$500,000100%